Financials data is unavailable for this security.
View more
Year on year Hologic 's revenues fell -17.12% from 4.86bn to 4.03bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 1.30bn to 456.00m, a -64.98% decrease.
Gross margin | 55.41% |
---|---|
Net profit margin | 17.59% |
Operating margin | 19.69% |
Return on assets | 7.70% |
---|---|
Return on equity | 13.85% |
Return on investment | 8.64% |
More ▼
Cash flow in USDView more
In 2023, Hologic increased its cash reserves by 17.79%, or 416.20m. The company earned 1.05bn from its operations for a Cash Flow Margin of 26.08%. In addition the company used 152.10m on investing activities and also paid 483.20m in financing cash flows.
Cash flow per share | 4.21 |
---|---|
Price/Cash flow per share | 18.77 |
Book value per share | 21.33 |
---|---|
Tangible book value per share | 4.19 |
More ▼
Balance sheet in USDView more
Current ratio | 3.99 |
---|---|
Quick ratio | 3.32 |
Total debt/total equity | 0.5169 |
---|---|
Total debt/total capital | 0.3408 |
More ▼